Clinical Trials for Olatec Therapeutics

Explore 4 clinical trials worldwide

Showing 1-4 of 4 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Olatec Therapeutics

Clinical Trials (4)

NCT07157735
A Trial to Test the Use of Dapansutrile, an Anti-inflammatory Medication, in People With Parkinson's Disease
PHASE2Not yet recruiting
36 participants
Started: Nov 30, 2025 · Completed: Feb 29, 2028
1 condition5 sponsors1 location
NCT06047262
Dapansutrile in Diabetes and Diabetes-Related Complications - Dapan-Dia
PHASE2Recruiting
300 participants
Started: Jul 9, 2024 · Completed: Jul 31, 2026
1 condition4 sponsors1 location
NCT05658575
Study of Dapansutrile Tablets in Subjects With an Acute Gout Flare
PHASE2/PHASE3Recruiting
300 participants
Started: Jan 6, 2023 · Completed: Dec 31, 2025
7 conditions1 sponsor39 locations
NCT04971499
A Study of Dapansutrile Plus Pembrolizumab in Patients With PD-1 Refractory Advanced Melanoma
PHASE1/PHASE2Recruiting
26 participants
Started: Sep 6, 2022 · Completed: Apr 30, 2026
1 condition3 sponsors1 location